
Aragen secures $100 million funding from Quadria Capital – Times of India
HYDERABAD: Contract research, development and manufacturing organisation (CRDMO) Aragen Life Science, formerly known as GVK Biosciences, has secured a $100 million (approx. Rs 865 crore) investment from healthcare focused private equity fund Quadria Capital.The deal will see Quadria, which is focused on the Asian healthcare sector, acquire a minority stake in Aragen at an approximate…